CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FierceBiotech
Original article

{"a":[{"_":"Regeneron pays $37M, adds $2B in biobucks to expand CytomX pact","$":{"href":"/biotech/regeneron-pays-37m-adds-2b-biobucks-expand-cytomx-pact","hreflang":"en"}}]}

Partnershipconditionally active bispecificsPositive
AI Analysis

Summary

Regeneron expands its research alliance with CytomX Therapeutics through a $37 million payment and $2 billion in additional biobucks, focusing on conditionally active bispecifics against two targets. The expansion increases the total potential deal value to approximately $4 billion.

Importance:7/10
Sentiment:
0.70
partnershipbispecificdeal expansionresearch collaboration
Related Companies

Read the original article

Published by FierceBiotech on June 3, 2026 9:32 AM

Read Original